Publications

5803 Results

Phase II trial of oral B-all trans-retinoic acid in hepatocellular carcinoma (SWOG-9157).

Authors
FL Meyskens Jr;J Jacobson;B Nguyen;GR Weiss;DR Gandara;JS Macdonald
Journal / Conference
Investigational New Drugs 16(2):171-173
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9157

Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial.

Authors
CM Moinpour;MJ Savage;A Troxel;LC Lovato;M Eisenberger;RW Veith;B Higgins;R Skeel;M Yee;BA Blumenstein;ED Crawford;FL Meyskens Jr
Journal / Conference
Journal of the National Cancer Institute 90(20):1537-1544
Year
1998
Research Committee(s)
Genitourinary

Biological features of acute myeloid leukemia in the elderly.

Authors
CP Leith;KJ Kopecky;CL Willman
Journal / Conference
Blood 92(2):697-699
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Characterization and use of an antibody detecting the CBFB-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.

Authors
DS Viswanatha;I Chen;PP Liu;ML Slovak;C Rankin;DR Head;CL Willman
Journal / Conference
Blood 91(6):1882-1890
Year
1998
Research Committee(s)
Leukemia

Trisomy 6 as a primary karyotypic aberration in hematologic disorders.

Authors
AN Mohamed;ML Varterasian;SM Dobin;TS McConnell;SR Wolman;C Rankin;CL Willman;DR Head;ML Slovak
Journal / Conference
Cancer Genetics and Cytogenetics 106:152-155
Year
1998
Research Committee(s)
Leukemia

Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein.

Authors
DE Hogge;CL Willman;RJ Kreitman;M Berger;PD Hall;KJ Kopecky;C McLain;EP Tagge;CJ Eaves;AE Frankel
Journal / Conference
Blood 92(2):589-595
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Paclitaxel for the treatment of lymphoma.

Authors
A Younes
Journal / Conference
Journal of Clinical Oncology 16(6):2289-2290
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9246

Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer (BC).

Authors
IC Henderson;D Berry;G Demetri;C Cirrincione;L Goldstein;S Martino;JN Ingle;MR Cooper;G Canellos;E Borden;G Fleming;JF Holland;S Graziano;J Carpenter;H Muss;L Norton
Journal / Conference
Proc of the American Society of Clinical Oncology 17:101a(#390a)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

Phase III intergroup trial of 13-cis-retinoic acid to prevent second primary tumors in stage-I non-small cell lung cancer (NSCLC): Interim report of NCI #191-0001.

Authors
SM Lippman;JJ Lee;DD Karp;EE Vokes;SE Benner;GE Goodman;C Kardinal;RJ Winn;JA Roth;WK Hong
Journal / Conference
Proc of the American Society of Clinical Oncology 17:456a(#1753)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9221 (MDACC, ID91-025) (INT-I91-0001)

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study.

Authors
CR Nichols;PJ Catalano;ED Crawford;NJ Vogelzang;LH Einhorn;PJ Loehrer
Journal / Conference
Journal of Clinical Oncology 16(4):1287-1293
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8997 (EST-3887) (ECOG-3887)